你即將離開本站

並前往https://www.fiercepharma.com/pharma/abbvie-touts-qulipta-chronic-migraine-prevention-win-oral-cgrp-fight-heats-biohaven

AbbVie touts Qulipta chronic migraine win as Biohaven duel ...

If approved, a label for preventive treatment of chronic migraine could give AbbVie a leg up in an ongoing tussle for oral CGRP market leadership against ...

確定！ 回上一頁

查詢 「Migraine Prevention」的人也找了：

  1. migraine中文
    2.
  2. Migraine
    3.
  3. Migraine treatment guidelines
    4.
  4. Migraine treatment
    5.
  5. Migraine treatment guidelines 2020
    6.
  6. Migraine prophylaxis
    7.
  7. Migraine uptodate
    8.
  8. Migraine aura
    9.